Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Physiol Cell Physiol
2012 May 15;30210:C1479-91. doi: 10.1152/ajpcell.00277.2011.
Show Gene links
Show Anatomy links
Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.
Wu G
,
Zhang W
,
Na T
,
Jing H
,
Wu H
,
Peng JB
.
???displayArticle.abstract???
Oculocerebrorenal syndrome of Lowe (OCRL) gene product is a phosphatidyl inositol 4,5-bisphosphate [PI(4,5)P(2)] 5-phosphatase, and mutations of OCRL cause Lowe syndrome and Dent disease, both of which are frequently associated with hypercalciuria. Transient receptor potential, vanilloid subfamily, subtype 6 (TRPV6) is an intestinal epithelial Ca(2+) channel mediating active Ca(2+) absorption. Hyperabsorption of Ca(2+) was found in patients of Dent disease with increased Ca(2+) excretion. In this study, we tested whether TRPV6 is regulated by OCRL and, if so, to what extent it is altered by Dent-causing OCRL mutations using Xenopus laevis oocyte expression system. Exogenous OCRL decreased TRPV6-mediated Ca(2+) uptake by regulating the function and trafficking of TRPV6 through different domains of OCRL. The PI(4,5)P(2) 5-phosphatase domain suppressed the TRPV6-mediated Ca(2+) transport likely through regulating the PI(4,5)P(2) level needed for TRPV6 function without affecting TRPV6 protein abundance of TRPV6 at the cell surface. The forward trafficking of TRPV6 was decreased by OCRL. The Rab binding domain in OCRL was involved in regulating the trafficking of TRPV6. Knocking down endogenous X. laevis OCRL by antisense approach increased TRPV6-mediated Ca(2+) transport and TRPV6 forward trafficking. All seven Dent-causing OCRL mutations examined exhibited alleviation of the inhibitory effect on TRPV6-mediated Ca(2+) transport together with decreased overall PI(4,5)P(2) 5-phosphatase activity. In conclusion, OCRL suppresses TRPV6 via two separate mechanisms. The disruption of PI(4,5)P(2) 5-phosphatase activity by Dent-causing mutations of OCRL may lead to increased intestinal Ca(2+) absorption and, in turn, hypercalciuria.
Attree,
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase.
1992, Pubmed
Attree,
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase.
1992,
Pubmed
Bianco,
Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene.
2007,
Pubmed
Bothwell,
Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.
2011,
Pubmed
Cho,
Renal manifestations of Dent disease and Lowe syndrome.
2008,
Pubmed
Choudhury,
Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.
2005,
Pubmed
Choudhury,
Differential clathrin binding and subcellular localization of OCRL1 splice isoforms.
2009,
Pubmed
DENT,
HYPERCALCURIC RICKETS ASSOCIATED WITH RENAL TUBULAR DAMAGE.
1964,
Pubmed
Devuyst,
Genetics of hypercalciuric stone forming diseases.
2007,
Pubmed
Devuyst,
Dent's disease.
2010,
Pubmed
Dressman,
Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells.
2000,
Pubmed
Erdmann,
A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.
2007,
Pubmed
Faucherre,
Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network.
2003,
Pubmed
Frick,
Molecular mechanisms of primary hypercalciuria.
2003,
Pubmed
Hoopes,
Dent Disease with mutations in OCRL1.
2005,
Pubmed
Hou,
A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.
2011,
Pubmed
Hyvola,
Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases.
2006,
Pubmed
Jefferson,
Mutation of the conserved domains of two inositol polyphosphate 5-phosphatases.
1996,
Pubmed
Jiang,
WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4.
2007,
Pubmed
,
Xenbase
Jiang,
WNK4 regulates the secretory pathway via which TRPV5 is targeted to the plasma membrane.
2008,
Pubmed
,
Xenbase
Johnson,
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
2003,
Pubmed
Jänne,
Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
1998,
Pubmed
Klausner,
Brefeldin A: insights into the control of membrane traffic and organelle structure.
1992,
Pubmed
LOWE,
Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.
1952,
Pubmed
Lloyd,
A common molecular basis for three inherited kidney stone diseases.
1996,
Pubmed
,
Xenbase
Lowe,
Structure and function of the Lowe syndrome protein OCRL1.
2005,
Pubmed
Luyckx,
Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression.
1999,
Pubmed
Mao,
A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.
2009,
Pubmed
Meyer,
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
2006,
Pubmed
Olivos-Glander,
The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex.
1995,
Pubmed
Peng,
Structural conservation of the genes encoding CaT1, CaT2, and related cation channels.
2001,
Pubmed
,
Xenbase
Peng,
Human calcium transport protein CaT1.
2000,
Pubmed
,
Xenbase
Peng,
Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption.
1999,
Pubmed
,
Xenbase
Piwon,
ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.
2000,
Pubmed
Ponting,
A novel domain suggests a ciliary function for ASPM, a brain size determining gene.
2006,
Pubmed
Reinhart,
Characterization of carrier females and affected males with X-linked recessive nephrolithiasis.
1995,
Pubmed
Ren,
Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes.
1998,
Pubmed
Scheel,
Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins.
2005,
Pubmed
,
Xenbase
Scheinman,
Nephrolithiasis.
1999,
Pubmed
Shrimpton,
OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability.
2009,
Pubmed
Silva,
The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover.
2003,
Pubmed
Sliman,
Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome.
1995,
Pubmed
Stenmark,
Rab GTPases as coordinators of vesicle traffic.
2009,
Pubmed
Suchy,
The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization.
2002,
Pubmed
Suchy,
Abnormal bradykinin signalling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1.
2009,
Pubmed
Suzuki,
Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.
2008,
Pubmed
,
Xenbase
Thyagarajan,
Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels.
2008,
Pubmed
Tosetto,
Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.
2009,
Pubmed
Ungewickell,
The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin.
2004,
Pubmed
Utsch,
Novel OCRL1 mutations in patients with the phenotype of Dent disease.
2006,
Pubmed
Van Cromphaut,
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects.
2001,
Pubmed
Vicinanza,
OCRL controls trafficking through early endosomes via PtdIns4,5P₂-dependent regulation of endosomal actin.
2011,
Pubmed
Wang,
Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.
2000,
Pubmed
Zerial,
Rab proteins as membrane organizers.
2001,
Pubmed
Zhang,
The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
1995,
Pubmed
Zhang,
Down-regulation of intestinal apical calcium entry channel TRPV6 by ubiquitin E3 ligase Nedd4-2.
2010,
Pubmed
,
Xenbase
Zhuang,
Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies.
2002,
Pubmed
van de Graaf,
Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane.
2006,
Pubmed
